EUVIMEDEUVIMED entdecken
Kohortenstudie

Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study

Ken Lund iD, Floor Dijkstra Zegers iD, Jan Nielsen iD, Jacob Broder Brodersen iD, Torben Knudsen iD, Jens Kjeldsen iD, Michael Due Larsen iD, Bente Mertz Nørgård iD

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad244 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Ken Lund und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Odense University Hospital Research Council, Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Real-world data on medications used for conditions other than inflammatory bowel disease (IBD) are sparse. We examined how the onset of IBD affects the prescription pattern of selected non-IBD medication and the risk of becoming an incident user.

Methods

This nationwide cohort study utilized data from Danish health registers. We included incident patients with young adult–onset IBD (18-39 years of age), adult-onset IBD (40-59 years of age), and elderly-onset IBD (60+ years of age), from 1998 to 2018 and followed all for 3 years. We examined redeemed prescriptions before and after the onset of IBD and estimated the risk of becoming a user of non-IBD medications using logistic regression models.

Results

We identified 36165 patients, 16 771 (46%) with young adult onset, 10615 (29%) with adult onset, and 8779 (24%) with elderly onset. The onset of IBD increased the use of antidepressants, antipsychotics, sedatives/hypnotics, opioids, nonopioid analgesics, antidiabetics, and proton pump inhibitors, even in patients with no other underlying comorbid diseases. The adjusted odds ratio for using antidepressants 1 year after the onset of IBD in elderly was 1.50 (95% confidence interval [CI], 1.14-1.82), in opioids 1.69 (95% CI, 1.45-1.95), in nonopioid analgesics 2.10 (95% CI, 1.77-2.48), in cardiovascular medication 2.20 (95% CI, 1.86-2.61), and in proton pump inhibitors 1.51 (95% CI, 1.31-1.74) compared with adults.

Conclusions

In all 3 age groups, the proportions of patients with redeemed prescriptions for several groups of non-IBD medication were significantly increased after the IBD diagnosis compared with before. The risk of becoming an incident user for several groups of non-IBD medication was increased in elderly patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesHumansMaleFemaleMiddle AgedDenmarkAdultAgedYoung AdultAdolescentCohort StudiesAntidepressive AgentsRegistriesHypoglycemic AgentsProton Pump InhibitorsAntipsychotic AgentsAnalgesics, OpioidHypnotics and SedativesDrug PrescriptionsAge of Onset

Stichwörter der Autor:innen

Crohn’s diseaseadultelderlyinflammatory bowel diseasenon-IBD medicationulcerative colitis

Substanzen

Antidepressive AgentsHypoglycemic AgentsProton Pump InhibitorsAntipsychotic AgentsAnalgesics, OpioidHypnotics and Sedatives

Autor:innen und Institutionen

  • Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark.
  • Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Medical Gastroenterology, Hospital of Southwest Jutland, Esbjerg, Denmark.
  • Department of Regional Health Science, University of Southern Denmark, Esbjerg, Denmark.
  • Department of Medical Gastroenterology - S, Odense University Hospital, Odense, Denmark.
  • Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Ken Lund, Floor Dijkstra Zegers, Jan Nielsen, Jacob Broder Brodersen, Torben Knudsen, Jens Kjeldsen, Michael Due Larsen, Bente Mertz Nørgård

Förderung

  • Odense University Hospital Research Council
  • Pfizer

Zitieren

APA

Lund, K., Zegers, F. D., Nielsen, J., Brodersen, J. B., Knudsen, T., Kjeldsen, J., Larsen, M. D., & Nørgård, B. M. (2024). Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad244

Vancouver

Lund K, Zegers FD, Nielsen J, Brodersen JB, Knudsen T, Kjeldsen J, et al. Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad244

BibTeX
@article{Lund2024,
  author = {Lund, Ken and Zegers, Floor Dijkstra and Nielsen, Jan and Brodersen, Jacob Broder and Knudsen, Torben and Kjeldsen, Jens and Larsen, Michael Due and Nørgård, Bente Mertz},
  title = {Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad244}
}
Kostenlos starten →